Signaling Processes for Initiating Smooth Muscle Contraction Upon Neural Stimulation
Overview
Affiliations
Relationships among biochemical signaling processes involved in Ca2+/calmodulin (CaM)-dependent phosphorylation of smooth muscle myosin regulatory light chain (RLC) by myosin light chain kinase (MLCK) were determined. A genetically-encoded biosensor MLCK for measuring Ca(2+)-dependent CaM binding and activation was expressed in smooth muscles of transgenic mice. We performed real-time evaluations of the relationships among [Ca2+](i), MLCK activation, and contraction in urinary bladder smooth muscle strips neurally stimulated for 3 s. Latencies for the onset of [Ca2+](i) and kinase activation were 55 +/- 8 and 65 +/- 6 ms, respectively. Both increased with RLC phosphorylation at 100 ms, whereas force latency was 109 +/- 3 ms. [Ca2+](i), kinase activation, and RLC phosphorylation responses were maximal by 1.2 s, whereas force increased more slowly to a maximal value at 3 s. A delayed temporal response between RLC phosphorylation and force is probably due to mechanical effects associated with elastic elements in the tissue. MLCK activation partially declined at 3 s of stimulation with no change in [Ca2+](i) and also declined more rapidly than [Ca2+](i) during relaxation. The apparent desensitization of MLCK to Ca2+ activation appears to be due to phosphorylation in its calmodulin binding segment. Phosphorylation of two myosin light chain phosphatase regulatory proteins (MYPT1 and CPI-17) or a protein implicated in strengthening membrane adhesion complexes for force transmission (paxillin) did not change during force development. Thus, neural stimulation leads to rapid increases in [Ca2+](i), MLCK activation, and RLC phosphorylation in phasic smooth muscle, showing a tightly coupled Ca2+ signaling complex as an elementary mechanism initiating contraction.
Nitric Oxide in Cardiac Surgery: A Review Article.
Kamenshchikov N, Duong N, Berra L Biomedicines. 2023; 11(4).
PMID: 37189703 PMC: 10135597. DOI: 10.3390/biomedicines11041085.
Taha S, Daabees T, Aly R, Senbel A Saudi Pharm J. 2022; 30(3):306-316.
PMID: 35498220 PMC: 9051969. DOI: 10.1016/j.jsps.2022.01.012.
Zuppone S, Bresolin A, Spinelli A, Fallara G, Luciano R, Scarfo F Front Oncol. 2020; 10:527121.
PMID: 33194587 PMC: 7642999. DOI: 10.3389/fonc.2020.527121.
Xie Y, Perrino B Anal Biochem. 2019; 577:1-13.
PMID: 30981700 PMC: 6548573. DOI: 10.1016/j.ab.2019.04.009.
Bassiouni W, Daabees T, Norel X, Senbel A Naunyn Schmiedebergs Arch Pharmacol. 2018; 392(4):437-450.
PMID: 30552456 DOI: 10.1007/s00210-018-01599-7.